Marrow Access Technologies and Spartan Medical partner to introduce advanced cartilage repair therapy for US veterans and Department of Defense members
Wednesday, August 30, 2023
Marrow Access Technologies has made an exciting announcement about its new partnership with Spartan Medical. This collaboration involves a distribution agreement that holds the potential to greatly impact healthcare for US veterans and Department of Defense personnel.
Under this agreement, patients within the Department of Veterans Affairs (VA) and Department of Defense (DoD) will gain access to the SmartShot® Marrow Access Device. This groundbreaking device is designed to tap into the body's innate healing capabilities by utilizing its own stem cells. It specifically addresses orthopedic soft tissue injuries in various areas such as the knee, hip, shoulder, foot, and ankle.
What sets this partnership apart is the strategic involvement of Spartan Medical, an enterprise that is both service-disabled and veteran-owned. Through this collaboration, Marrow Access Technologies gains access to the extensive federal marketplace linked with the Veterans Health Administration. This administration caters to a vast network of over 9.1 million veterans, making it a pivotal point of healthcare.
The unique aspect of the SmartShot® Marrow Access Device lies in its patented mechanism, which involves micro-needle channels penetrating deep into the bone. This process triggers the body's natural healing response, allowing blood and stem cells from the bone marrow to activate and accelerate healing for various components like cartilage, ligaments, bones, and tendons.